Novartis Shares Decline As Spin Off Sandoz’s Market Debut Falls Short of Expected Valuation – Beragampengetahuan
Novartis also reiterated its focused approach to capital allocation, including the ongoing $15 billion share buy-back announced in July 2023 and to continue paying an annual dividend, up from the CHF … Read Full Story at source (may require registration) The post Novartis Shares Decline As Spin Off Sandoz’s Market Debut Falls Short of Expected […]